Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: A prospective, randomized, multicenter trial.

被引：0
|
作者：
Minematsu, K [1 ]
Yasaka, M [1 ]
Yamaguchi, T [1 ]
机构：
[1] Natl Cardiovasc Ctr, Osaka, Japan
来源：
STROKE | 1999年 / 30卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
60
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [21] Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
    Piccini, Jonathan P.
    Hellkamp, Anne S.
    Washam, Jeffrey B.
    Becker, Richard C.
    Breithardt, Guenter
    Berkowitz, Scott D.
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Hacke, Werner
    Mahaffey, Kenneth W.
    Nessel, Christopher C.
    Singer, Daniel E.
    Fox, Keith A. A.
    Patel, Manesh R.
    [J]. CIRCULATION, 2016, 133 (04) : 352 - 360
  • [22] Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention
    Hirano, Teruyuki
    Kaneko, Hirokazu
    Mishina, Sari
    Wang, Feng
    Morita, Satoshi
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (10): : 2102 - 2110
  • [23] Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation
    Spivey, Christina A.
    Qiao, Yanru
    Liu, Xianchen
    Mardekian, Jack
    Parker, Robert B.
    Phatak, Hemant
    Claflin, Abigail B.
    Kachroo, Sumesh
    Abdulsattar, Younos
    Chakrabarti, Anwesa
    Wang, Junling
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (07): : 596 - 606
  • [24] The influence of rivaroxaban versus warfarin therapy for stroke prevention in hospital resource utilization in nonvalvular atrial fibrillation patients.
    Jain, Barkha
    Brunetti, Luigi
    [J]. PHARMACOTHERAPY, 2017, 37 (06): : E55 - E55
  • [25] Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation
    Lam, Yat-Yin
    Ma, Terry K. W.
    Yan, Bryan P.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 150 (01) : 4 - 11
  • [26] Edoxaban or standard therapy with warfarin for stroke prevention in patients with atrial fibrillation
    Plitt, Anna
    Giugliano, Robert P.
    [J]. FUTURE CARDIOLOGY, 2014, 10 (02) : 153 - 155
  • [27] Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared with Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation
    Fu, Mingjie
    Qin, Zheng
    Zheng, Shuai
    Li, Yueping
    Yang, Shiwei
    Zhao, Yingxin
    Hu, Chengping
    Zhou, Kuo
    Zhou, Yujie
    Meng, Xu
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (01): : 50 - 56
  • [28] Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared With Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation
    Gao, Sophie Weiwei
    Belley-Cote, Emilie Prudence
    Um, Kevin John
    Whitlock, Richard Paul
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (08): : 1385 - 1385
  • [29] Surgical left atrial appendage occlusion for stroke prevention compared with long-term warfarin therapy in patients with nonvalvular atrial fibrillation
    Fu, M.
    Qin, Z.
    Meng, X.
    Li, Y.
    Zhou, Y. J.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 826 - 826
  • [30] Effectiveness and Safety of Apixaban and Rivaroxaban Versus Warfarin for the Secondary Prevention of Stroke or Systemic Embolism Among Nonvalvular Atrial Fibrillation Patients
    Coleman, Craig
    Bunz, Thomas
    [J]. NEUROLOGY, 2017, 88
12345